Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 24,270 shares at $12.92 ($314K) on 2020-06-25, disclosed to the SEC on 2020-06-26.
Open-market sale of $314k ATRA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.92 | 12,135 | $157K | 50.0% |
| 2 | $12.92 | 12,135 | $157K | 50.0% |
| Total | $12.92 avg | 24,270 | $314K | 100% |
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |